SIRT5 and acute myeloid leukemia: Disabling SIRT5 in AML (through CRISPR or RNAi) leads to a failure of leukemic cells to proliferate and induce apoptosis while having relatively minor effects on normal hematopoietic cells (Yan et al. 2021; Juszczak et al. 2024).